Tag: Indian Pharma

Wockhardt to exit US generic pharma segment to unlock capital for high-impact areas

Wockhardt to exit US generic pharma segment to unlock c...

ASJ Stock Market C... Jul 12, 2025 0 0

Wockhardt is exiting the US generic pharmaceutical segment to reallocate capital...

IPO-bound Anthem Bio says cost arbitrage drove expansion, proposing China alternative for global pharma

IPO-bound Anthem Bio says cost arbitrage drove expansio...

ASJ Stock Market C... Jul 10, 2025 0 0

IPO-bound Anthem Biosciences bets on India's cost arbitrage to replace China in ...

Accumulate Torrent Pharmaceuticals; target of Rs 3850: Prabhudas Lilladher

Accumulate Torrent Pharmaceuticals; target of Rs 3850: ...

ASJ Stock Market C... Jul 1, 2025 0 0

Prabhudas Lilladher recommends ‘Accumulate’ on Torrent Pharmaceuticals with a ta...

Ozempic, a patent challenge, and the $25 billion race for India’s weight-loss drug market

Ozempic, a patent challenge, and the $25 billion race f...

ASJ Stock Market C... Jun 19, 2025 0 0

As Ozempic revolutionizes weight-loss treatment globally, India emerges as a bat...

LIC raises stake in Dr. Reddy’s Laboratories to 8.21%. Details here

LIC raises stake in Dr. Reddy’s Laboratories to 8.21%. ...

ASJ Stock Market C... Jun 5, 2025 0 0

LIC has raised its stake in Dr. Reddy’s Laboratories from 5.02% to 8.21%. Find o...